Company: BDRX
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001214659-25-006756
Chunk: 84

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-01
Form: DRS
Chunk 84
---
| 46 |

Under a deed poll declared by us on August
5, 2015, or a Deed of Indemnity, our Board of Directors and our Company Secretary are indemnified against costs and liabilities incurred
in connection with their office, other than any liability owed by such person to the Company itself (or any of our associated entities)
and other than indemnification for liabilities in certain circumstances, which are prohibited by virtue of the Companies Act. The Deed
of Indemnity provides that a director may also be lent sums to finance any relevant defense costs, provided that, in the event such proceedings
involve criminal or civil matters in which the person is convicted or has a judgment made against him or her, then such loan must be repaid.
Our total aggregate liability of Biodexa under the Deed of Indemnity is £5 million.

Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to a charter provision,
by-law, contract, arrangements, statute or otherwise, we acknowledge that in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable.

Other United Kingdom Law Considerations

Mandatory Purchases and Acquisitions

Pursuant to Sections 979 to 991 of the Companies
Act, where a takeover offer has been made for us and the offeror has acquired or unconditionally contracted to acquire not less than 90%
in value of the shares to which the offer relates and not less than 90% of the voting rights carried by those shares, the offeror may
give notice to the holder of any shares to which the offer relates which the offeror has not acquired or unconditionally contracted to
acquire that he wishes to acquire, and is entitled to so acquire, those shares on the same terms as the general offer. The offeror would
do so by sending a notice to the outstanding minority shareholders telling them that it will compulsorily acquire their shares. Such notice
must be sent within three months of the last day on which the offer can be accepted in the prescribed manner. The squeeze-out of the minority
shareholders can be completed at the end of six weeks from the date the notice has been given, following which the offeror can execute
a transfer of the outstanding shares in its favor and pay the consideration to us, and we would hold the consideration on trust for the